Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Statins291 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16435 | 28391883 | J Clin Lipidol | Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases. | 2016 | Details |
| A16650 | 28265826 | Dig Dis Sci | Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients. | 2017 | Details |
| A16796 | 28167864 | J Inflamm (Lond) | Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs. | 2017 | Details |
| A17054 | 28025996 | Int J Mol Med | Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17204 | 27914698 | Nutr Metab Cardiovasc Dis | Under-prescription of statins in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17365 | 27822971 | Expert Opin Drug Metab Toxicol | Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? | 2016 | Details |
| A17384 | 27812789 | Obes Surg | Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A17438 | 27396601 | Curr Pharm Des | Lipids, Statins and Heart Failure: An Update. | 2016 | Details |
| A17490 | 27767079 | Sci Rep | SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy. | 2016 | Details |
| A17506 | 27098507 | Diabetes Metab J | Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice. | 2016 | Details |
| A17623 | 27710158 | Postgrad Med | Hypertriglyceridemia: the importance of identifying patients at risk. | 2016 | Details |
| A17655 | 29416297 | Hippokratia | The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease. | 2020 | Details |
| A17727 | 27634010 | Am J Physiol Gastrointest Liver Physiol | Statins improve NASH via inhibition of RhoA and Ras. | 2016 | Details |
| A18205 | 27287838 | Orv Hetil | [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. | 2016 | Details |
| A18292 | 27237577 | Metabolism | Non-alcoholic fatty liver disease and dyslipidemia: An update. | 2016 | Details |
| A18392 | 27166128 | Am J Gastroenterol | Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study. | 2016 | Details |
| A18464 | 27110380 | BMJ Open Gastroenterol | Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease. | 2016 | Details |
| A18523 | 27073470 | Exp Ther Med | Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease. | 2016 | Details |
| A19034 | 26810159 | Diabetes Metab Syndr | Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. | 2016 | Details |
| A19201 | 26707137 | Dig Dis Sci | Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia. | 2015 | Details |
| A19678 | 28294798 | Kardiologiia | [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. | 2015 | Details |
| A19881 | 26288848 | EBioMedicine | Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A19885 | 26284591 | Clin Gastroenterol Hepatol | Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. | 2015 | Details |
| A19967 | 26234727 | Metabolism | Nonalcoholic fatty liver disease and statins. | 2015 | Details |
| A20094 | 26159280 | Dig Dis | Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. | 2015 | Details |
| A20099 | 26155623 | Ter Arkh | [Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20101 | 26155039 | J Clin Exp Hepatol | Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors. | 2015 | Details |
| A20221 | 26078558 | World J Gastroenterol | Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. | 2015 | Details |
| A20373 | 26005676 | Hepatobiliary Surg Nutr | Fatty liver disease in diabetes mellitus. | 2015 | Details |
| A20417 | 25980762 | J Hepatol | Statin use and non-alcoholic steatohepatitis in at risk individuals. | 2015 | Details |
| A20533 | 25906659 | Lik Sprava | [Optimization of long-term treatment with rosuvastatin of patients with myocardial infarction in combination with non-alcoholic steatohepatitis]. | 2015 | Details |
| A20560 | 25886887 | BMC Gastroenterol | Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. | 2015 | Details |
| A20712 | 25786512 | Liver Int | Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. | 2015 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A21123 | 25528845 | Lik Sprava | [Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis]. | 2014 | Details |
| A21398 | 25349644 | World J Hepatol | Lipid-lowering agents in the management of nonalcoholic fatty liver disease. | 2014 | Details |
| A21427 | 25327387 | Expert Rev Gastroenterol Hepatol | Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. | 2014 | Details |
| A21564 | 25224698 | Dig Liver Dis | The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A21823 | 25024593 | World J Gastroenterol | Modern approach to the clinical management of non-alcoholic fatty liver disease. | 2014 | Details |
| A21992 | 24905085 | Liver Int | Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A22110 | 24815080 | Dig Liver Dis | Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. | 2014 | Details |
| A22140 | 24793441 | J Clin Lipidol | An assessment by the Statin Liver Safety Task Force: 2014 update. | 2014 | Details |
| A22147 | 24788803 | Drug Saf | Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases. | 2014 | Details |
| A22171 | 24768901 | J Hepatol | Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte. | 2014 | Details |
| A22219 | 24743428 | Arterioscler Thromb Vasc Biol | Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. | 2014 | Details |
| A22310 | 24673432 | Expert Opin Pharmacother | Treatment options for managing atherogenic dyslipidemia and fatty liver disease. | 2014 | Details |
| A22371 | 24633023 | Intern Med | Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes. | 2014 | Details |
| A22373 | 24632765 | Minerva Gastroenterol Dietol | Use of statins in patients with liver disease. | 2014 | Details |
| A22429 | 24587650 | World J Gastroenterol | Clinical approaches to non-alcoholic fatty liver disease. | 2014 | Details |
| A22572 | 24455970 | Ren Fail | Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients. | 2014 | Details |
| A22598 | 24428677 | Expert Opin Pharmacother | New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. | 2014 | Details |
| A22610 | 24417071 | Klin Med (Mosk) | [Obesity and diseases of digestive organs]. | 2013 | Details |
| A22643 | 24388027 | Mayo Clin Proc | Drug-induced liver injury. | 2014 | Details |
| A22659 | 24378270 | Ann Hepatol | Statin use is not associated with liver related mortality. | 2014 | Details |
| A22668 | 24374462 | Cochrane Database Syst Rev | Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2013 | Details |
| A22749 | 24333254 | Arch Med Res | Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease. | 2013 | Details |
| A22752 | 24329852 | J Viral Hepat | Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy? | 2013 | Details |
| A22879 | 24259612 | Ann Pharmacother | Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. | 2013 | Details |
| A22925 | 24206433 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. | 2013 | Details |
| A22970 | 24159791 | Klin Med (Mosk) | [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type]. | 2013 | Details |
| A22997 | 24127654 | Curr Med Res Opin | Are statins 'IDEAL' for non-alcoholic fatty liver disease? | 2013 | Details |
| A23100 | 24040875 | Curr Pharm Des | The role of statins in the treatment of type 2 diabetes mellitus: an update. | 2014 | Details |
| A23266 | 23915136 | Thyroid | Thyroid hormone analogues: where do we stand in 2013? | 2013 | Details |
| A23278 | 23905912 | Exp Clin Transplant | Effect of ethnicity on liver transplant for hepatocellular carcinoma. | 2013 | Details |
| A23297 | 23889731 | Expert Opin Investig Drugs | Statins and nonalcoholic fatty liver disease: a bright future? | 2013 | Details |
| A23354 | 23847661 | Arch Med Sci | Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. | 2013 | Details |
| A23618 | 23623999 | J Hepatol | PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism. | 2013 | Details |
| A23706 | 23548993 | Tumori | Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back. | 2013 | Details |
| A23784 | 23482703 | World J Gastroenterol | NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. | 2013 | Details |
| A23906 | 23394094 | Curr Pharm Des | Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? | 2013 | Details |
| A23983 | 23328905 | Curr Atheroscler Rep | Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review. | 2013 | Details |
| A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |
| A24008 | 23304532 | Int J Hepatol | Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease. | 2012 | Details |
| A24025 | 23295058 | Liver Int | Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats. | 2013 | Details |
| A24188 | 23140546 | Curr Vasc Pharmacol | The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. | 2013 | Details |
| A24195 | 23131380 | Complement Ther Med | The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. | 2012 | Details |
| A24307 | 26181068 | Clin J Gastroenterol | Nonalcoholic fatty liver disease: from lipid profile to treatment. | 2012 | Details |
| A24540 | 22788090 | Rom J Intern Med | Non-alcoholic fatty liver disease and the statins treatment. | 2012 | Details |
| A24543 | 22770622 | Expert Opin Pharmacother | The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. | 2012 | Details |
| A24655 | 25755424 | J Clin Exp Hepatol | Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis. | 2012 | Details |
| A24674 | 22617751 | Curr Opin Lipidol | Nonalcoholic fatty liver disease and lipids. | 2012 | Details |
| A24700 | 22583925 | Hepatol Res | Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study. | 2012 | Details |
| A24723 | 22560219 | Cell Metab | Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24852 | 22432744 | J Gastroenterol Hepatol | Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. | 2012 | Details |
| A24865 | 22419057 | Dig Dis Sci | Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies. | 2012 | Details |
| A24872 | 22418885 | Semin Liver Dis | Dyslipidemia in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24984 | 22278337 | Diabetologia | Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. | 2012 | Details |
| A25186 | 22108148 | J Clin Lipidol | 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. | 2011 | Details |
| A25253 | 22043827 | Expert Opin Pharmacother | Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions. | 2011 | Details |
| A25299 | 21986643 | Curr Opin Lipidol | Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update. | 2011 | Details |
| A25670 | 21563361 | Eksp Klin Gastroenterol | [Advisability of using probiotics in the treatment of atherogenic dyslipidemia]. | 2011 | Details |
| A25675 | 21560640 | Eksp Klin Gastroenterol | [Gastroenterological aspects of atherosclerosis]. | 2011 | Details |
| A25730 | 21499089 | Curr Opin Cardiol | Liver function tests and statins. | 2011 | Details |
| A25771 | 21476786 | Ann Med | Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? | 2011 | Details |
| A26020 | 22629789 | Eksp Klin Gastroenterol | [UDCA in the treatment of nonalcoholic fatty liver disease]. | 2011 | Details |
| A26021 | 22629725 | Eksp Klin Gastroenterol | [UDCA in the treatment of nonalcoholic fatty liver disease]. | 2011 | Details |
| A26098 | 21109302 | Lancet | Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. | 2010 | Details |
| A26113 | 21073649 | Liver Int | Angiogenesis in chronic liver disease and its complications. | 2010 | Details |
| A26132 | 21044019 | Curr Vasc Pharmacol | Ezetimibe; more than a low density lipoprotein cholesterol lowering drug? An update after 4 years. | 2011 | Details |
| A26152 | 21033080 | Eksp Klin Gastroenterol | [Hypolipidemic therapy in patients with non-alcoholic fatty liver disease]. | 2010 | Details |